US 10676474
1,6-naphthyridine derivatives as CDK4/6 inhibitor
granted A61KA61K31/4375A61K31/4965
Quick answer
US patent 10676474 (1,6-naphthyridine derivatives as CDK4/6 inhibitor) held by Medshine Discovery Inc. expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4375, A61K31/4965, A61P, A61P35/00